方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| QSAR× | 药效团建模× | |
|---|---|---|
| 领域 | 生物信息学 | 生物信息学 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1964 | 1977 |
| 提出者≠ | Corwin Hansch | Peter Gund |
| 类型≠ | Regression-based predictive modeling pipeline | Pattern-based virtual screening pipeline |
| 开创性文献≠ | Hansch, C. & Fujita, T. (1964). Rho-sigma-pi analysis. A method for the correlation of biological activity and chemical structure. Journal of the American Chemical Society, 86(8), 1616-1626. DOI ↗ | Wermuth, C. G., Ganellin, C. R., Lindberg, P., & Mitscher, L. A. (1998). Glossary of terms used in medicinal chemistry. Pure and Applied Chemistry, 70(5), 1129-1143. DOI ↗ |
| 别名 | QSAR model, quantitative structure-activity relationship | pharmacophore pattern recognition, 3D pharmacophore |
| 相关 | 3 | 3 |
| 摘要≠ | Quantitative Structure-Activity Relationship (QSAR) modeling predicts biological activity from molecular structure using statistical or machine learning models. Pioneered by Hansch in 1964, QSAR correlates numerical molecular descriptors with measured bioactivity, enabling prediction of activity for untested compounds and rational lead optimization. | Pharmacophore modeling identifies the spatial arrangement of molecular features (hydrogen bond donors, acceptors, aromatic rings) that are essential for biological activity. Introduced by Gund in 1977, this ligand-based method creates a three-dimensional pattern that can screen chemical libraries and design new active compounds without requiring receptor structure. |
| ScholarGate数据集 ↗ |
|
|